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Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Associated with Mutations in the Desmosomal Gene
Desmocollin-2
Petros Syrris, Deirdre Ward, Alison Evans, Angeliki Asimaki, Estelle Gandjbakhch,
Srijita Sen-Chowdhry, and William J. McKenna
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited myocardial disorder associated
with arrhythmias, heart failure, and sudden death. To date, mutations in four genes encodingmajor desmosomal proteins
(plakoglobin, desmoplakin, plakophilin-2, and desmoglein-2) have been implicated in the pathogenesis of ARVD/C. We
screened 77 probands with ARVD/C for mutations in desmocollin-2 (DSC2), a gene coding for a desmosomal cadherin.
Two heterozygous mutations—a deletion and an insertion—were identiﬁed in four probands. Both mutations result in
frameshifts and premature truncation of the desmocollin-2 protein. For the ﬁrst time, we have identiﬁed mutations in
desmocollin-2 in patients with ARVD/C, a ﬁnding that is consistent with the hypothesis that ARVD/C is a disease of the
desmosome.
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Arrhythmogenic right ventricular dysplasia/cardiomyop-
athy (ARVD/C [MIM #107970]) is an inheritedmyocardial
disorder associated with ventricular arrhythmias, heart fail-
ure, and sudden death.1,2 The main pathologic character-
istic of ARVD/C is loss of myocardium, predominately in
the right ventricle, and its replacement with adipose and
ﬁbrous tissue.3 Familial ARVD/C is believed to account for
at least 30%–50%of all cases,4 although penetrance in some
families is estimated to be !30%.5
To date, six genes have been implicated in the patho-
genesis of the disease. Four of them—plakoglobin, desmo-
plakin, plakophilin-2, and desmoglein-2—encode major
desmosomal proteins,6–17 a fact that indicates that ARVD/
C may be a disease of cell adhesion. A recessive mutation
in plakoglobin was found in Naxos disease, a syndrome
of ARVD/C, with phenotypes palmoplantar keratoderma
and woolly hair.6 Dominant mutations in desmoplakin
have been shown to cause ARVD/C,7–9 whereas recessive
mutations in this gene have been reported in cases of com-
bined phenotypes of cardiomyopathy and skin/hair ab-
normalities.10,11 A large number of disease-causing muta-
tions have been identiﬁed for plakophilin-2, which sug-
gests that this gene plays a major role in the pathogenesis
of ARVD/C.12–15 Recent studies have reported mutations
in a fourth desmosomal gene, desmoglein-2 (DSG2), in
familial cases of ARVD/C.16,17
In addition, two nondesmosomal genes have been
associated with speciﬁc types of ARVD/C: patients with
catecholaminergic polymorphic ventricular tachycardia
have mutations in the cardiac ryanodine receptor gene
(ARVD2),18,19 and transforming growth factor b3 has been
proposed as the disease gene in ARVD1.20 Desmosomes are
adhesive cell-cell junctions in epithelia and cardiacmuscle
that anchor the intermediate ﬁlament cytoskeleton to the
cytoplasmic membrane.21 In addition to providing tissues
with structural strength, desmosomes also participate in
morphogenesis and differentiation.21 Proteins belonging
to three main families are found in desmosomes: plakins,
armadillo repeat proteins, and cadherins.
Desmosomal cadherins, desmocollins, and desmogleins
are type I membrane glycoproteins responsible for medi-
ating adhesion.22 In humans, there are three desmocollin
isoforms (DSC1–3) that are encoded by genes clustered on
chromosome 18. Of them, DSC2 is ubiquitously expressed
in desmosomal tissues, and it appears to be the only des-
mocollin isoform present in cardiac tissue.23 DSC2, like
classic cadherins, contains ﬁve extracellular domains atis
the amino terminus, a single transmembrane-spanning
domain, and a cytoplasmic tail at the carboxy terminus.24
DSC2 is found in two variants, which are produced by
alternate splicing of exon 16.24 Desmocollins bind to des-
mogleins through their extracellular domains in a Ca2-
dependent manner,25 whereas their cytoplasmic domains
have binding sites for plakoglobin.26
There have been reports of DSG2 mutations in patients
with ARVD/C,16,17 and desmocollin-2 remains the only
major desmosomal protein expressed in cardiac tissue that
has not yet been implicated in the pathogenesis of the
disorder. Since DSC2 represents a plausible candidate gene
for ARVD/C, we screened 77 consecutive white patients
who received the diagnosis of ARVD/C (who were free of
mutations in plakoglobin, desmoplakin, plakophilin-2, and
DSG2) for mutations in DSC2. Informed consent was ob-
tained from all participating individuals. The study was
approved by the relevant hospital ethics committee. Clin-
ical evaluation was performed as described elsewhere,13
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Table 1. Intronic Primer Sequences Used for PCR
Ampliﬁcation and Sequencing of DSC2
Exon(s)
Primer Sequence
(5′r3′)
Sense Antisense
1 AGCAGCGGGCCCAGACTGCGCT GTTTTCCTCTGCACCCTAGGCG
2 GCCTTTTTATGTGTATATCAT TTCCTTTTTATGGCTGTGTAG
3 CACGTGCATACATTACTGTTAA GTAATGTTGATTACGTCTGAAG
4 GTCATTGTTTAATGTTTGAGAA ATAATGGTAAGAGATGGAAACT
5 ATAGATGAAAGCTCTGCTGAA AAATGGCCAAGCATCATCATT
6 TGAATTTGAAGCATACCTCAT TGTATGAATTGAAACACAGTT
7 ATAAAGGGAACATAGAACATGT GAGTTATACAGGTACTATTGAA
8 GGAGTGTAAAGTAAGATTTCAA CAGAGATGTGCATATTAAACAA
9 GTGCTAGGGTTTCAAATCATG CTTTCCATTAAATTCTAGCATGC
10 GCATTGCCAAATATTAAATGA GCTAAATTATAATAACGTAAC
11 GCAGTGGCATAAGGTACTTACC AACAGAGTGCATGTATCCAGC
12 TCAGTGCATACTTTTGTGGTGA AGTATCGCAGACATCCTGATGT
13 AGAAGAAATCAGTGACATTGTA CTTGAAAGTTACTTTAAAGGGT
14 TGTGTGTATTAACCATTGTACA TACGCATTATAAGCGAATTCAT
15 GGCATTATCCGCTTGATGTTGTTC CAATTAGTAGAATTAGTAGATTC
16 and 17a GCTATACTGAATTTATAGTGTGAT TAAAAGTCATAAAGCCACTGGCTT
a Exons 16 and 17 were ampliﬁed as a single PCR amplicon.
according to the International Task Force of the European
Society of Cardiology and International Society and Fed-
eration of Cardiology (ESC/ISFC) diagnostic criteria27 for
ARVD/C and the proposed modiﬁed diagnostic criteria.28
In brief, as determined by their speciﬁcity, clinical and ge-
netic features of the disease are divided into major and
minor criteria. The presence of two major, one major and
two minor, or four minor criteria from different categories
is considered diagnostic proof of disease. A set of modiﬁed
diagnostic criteria were subsequently proposed, to facili-
tate diagnosis in the setting of familial ARVD/C.28
DNA from whole blood and parafﬁn-embedded tissue
(from the family B proband) was extracted using QIAamp
DNA mini kits (Qiagen). Primer pairs for all DSC2 exons
were designed from ﬂanking intronic sequences that were
based on the published sequence of the two forms of the
desmocollin-2 gene (DSC2a and DSC2b [GenBank acces-
sion numbers NM_024422 and NM_004949, respectively)
(table 1). PCR ampliﬁcation was performed using standard
protocols (AmpliTaqGold [Applied Biosystems]). PCRprod-
ucts were sequenced in both directions on an Applied Bio-
systems 3130 Genetic Analyzer, with use of BigDye Ter-
minator chemistry (v3.1), and were analyzed by Seqscape
v2.5 software (Applied Biosystems).
Two heterozygous DSC2 mutations—a deletion and an
insertion—were detected in four probands and three fam-
ily members. Neither mutation was found in 200 white
volunteers.
In family A, a deletion of a single nucleotide (1430delC)
was detected in exon 10 of DSC2 in two individuals: the
proband (III.1) and her mother (II.2) (ﬁg. 1A). It leads to
a frameshift and a premature termination codon at posi-
tion 480 (M477fsX480). Three family members (III.2, III.3,
and III.4) were homozygous for the wild-type sequence.
Affected individuals from families B, C, and D carried
an insertion of two bases in exon 17 (2687_2688insGA)
(ﬁg. 1B). This mutation is predicted to generate a termina-
tion codon 4 aa residues downstream (E896fsX900).
The proband (III.2) in family B died suddenly at age 15
years. Her postmortem examination showed extensive ﬁ-
brofatty replacement of the right ventricularmyocardium,
which is consistent with a diagnosis of ARVD/C. The pres-
ence of the E896fsX900 mutation was conﬁrmed in car-
diac tissue preserved at postmortem examination. Her fa-
ther (II.1) and one sister (III.1) also carried this mutation.
Her other sister (III.3) declined genetic testing; her clinical
evaluation was normal. There is no other family history
of premature sudden death.
In family C, the proband (II.2) had diagnostic features
of ARVD/C and carried the E896fsX900 mutation. Her
brother (II.3) died suddenly at age 40 years, and post-
mortem ﬁndings were consistent with ARVD/C. However,
cardiac tissue was not made available for genotyping.
In family D, the proband (II.2) could not be assessed for
repolarization/depolarization abnormalities because elec-
trocardiogram (ECG) results indicated that she had a left
bundle branch block; therefore, she does not fulﬁll diag-
nostic criteria for ARVD/C. Her father (I.1) had apremature
sudden death at age 30 years, but no postmortem exami-
nation was performed. The proband’s daughters (III.1 and
III.2) declined clinical and genetic evaluation.
In all families, individuals who were homozygous for
the wild-type alleles were normal on clinical evaluation.
Clinical data about mutation carriers are summarized in
table 2.
For the ﬁrst time, to our knowledge, we describe mu-
tations in the desmocollin-2 gene in families with ARVD/
C. Interestingly, to date, no mutations in human desmo-
collin isoforms have been reported. Of the three isoforms,
only DSC1 has been implicated in human disease, since
it was identiﬁed as an autoantigen for subcorneal pustular
dermatosis-type IgA pemphigous.29 This is in marked con-
trast with the involvement of desmoglein isoforms in sev-
eral diseases, including ARVD/C, striate palmoplantar ker-
atoderma, and autoimmune disorders.16,17,30–32 However,
animal studies have shown that Dsc1-null mice exhibit
severe skin abnormalities due to loss of cell-cell adhesion.33
Desmosomal cadherins, through theirwell-documented
adhesive functions, regulate desmosomal adhesion and
formation and are also involved in tissue differentiation.34
The desmocollin-2 protein comprises the extracellular
amino terminal EC1–EC4 domains, an extracellular an-
chor domain (EA), a short transmembrane domain (TM),
an intracellular anchor domain (IA), and the intracellular
cadherin-binding domain (ICS) (ﬁg. 2).
The two DSC2 mutations described in this study are
considered to be pathogenic, since they result in frame-
shifts and premature termination codons. In particular, in
family A, mutation M477fsX480 is in the fourth extra-
cellular cadherin repeat (EC4) and is predicted to truncate
approximately one-half of the desmocollin-2 protein,with
loss of the transmembrane and cytoplasmic components.
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Figure 1. Pedigrees of families A–D and sequence electropherograms of DSC2 showing mutant sequences compared with a normal
control. Blackened symbols indicate individuals fulﬁlling ESC/ISFC diagnostic criteria for ARVD/C and/or those conﬁrmed as affected
at postmortem examination27; a gray symbol indicates individuals fulﬁlling the modiﬁed diagnostic criteria only28; white symbols indicate
unaffected individuals; slanted bars indicate deceased individuals; plus () and minus () signs indicate the presence or absence,
respectively, of a mutation in DSC2; an asterisk (*) indicates an individual who declined clinical evaluation and/or genetic testing;
squares indicate males; circles indicate females. The index patient in each family is marked with an arrow. A, Family A. Affected individuals
carry the M477fsX480 mutation. B, Families B–D. Affected individuals carry the E896fsX900 mutation. In family D, individual II.2 does
not fulﬁll diagnostic criteria, because she has predominantly left ventricular disease.
It can be speculated that this leads to a completely non-
functional mutant protein; however, it is more likely that
this deletion causesDSC2 haploinsufﬁciency bynonsense-
mediated mRNA decay.
Alternative splicing of exon 16 produces two DSC2 iso-
forms (DSC2a [long form] and DSC2b [short form]) with
DSC2b lacking the entire ICS.24 In contrast, inDSC2a, exon
17 encodes the ICS domain, which displays a high degree
of amino acid homology among various desmosomal and
nondesmosomal cadherins. It is believed that the binding
site to plakoglobin is located within this functionally im-
portant domain.35 In particular, the last 37 aa residues in
Table 2. Clinical Data for ARVD/C-Affected Families
Family
and Subject
Age
(in years)
Symptom(s)
Family
History
Abnormalities
Arrhythmia
No. of
Diagnostic
Criteria
(Major/Minor) GenotypeCurrent
At
Diagnosis
Depolarization/
Conduction Repolarization
Right Ventricle
Structure
A:
III.1 43 42 Syncope  Minor  Major Minor 1/2a M477fsX480
II.2 78  Palpitations Minor   Minor Minor 0/3b M477fsX480
B:
III.2 Deceased 15 Syncope   Minor Minor Minor 1/3a E896fsX900
II.1 59 59 Palpitations, syncope Major Major  Minor  2/1a E896fsX900
III.1 19 19  Major   Minor Minor 1/2a E896fsX900
III.3 13   Major     1/0 Declined investigation
C:
II.2 42 42 Palpitations Major   Major Minor 2/1a E896fsX900
II.3 Deceased 40 Cardiac arrest  NP NP  NP 1/0 Cardiac tissue not available
II.4 43   Major     1/0 Declined investigation
D:
II.2 65 60 Shortness of breath,
presyncope, palpitations
Minor NA NA Minor Minor 0/3c E896fsX900
NOTE.—A minus sign () p absent; NA p not appropriate because of presence, on ECG, of left bundle branch block; NP p not performed.
a Fulﬁlls ESC/ISFC criteria for a diagnosis of ARVD/C.27 For individuals III.2 (family B) and II.3 (family C), disease was conﬁrmed at postmortem examination (major criterion).
b Does not fulﬁll diagnostic criteria but, in the setting of a positive family history, does have features suggestive of ARVD/C and would satisfy the proposed modiﬁed criteria.28
c Does not fulﬁll ESC/ISFC criteria and has predominantly left ventricular disease.
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Figure 2. Schematic structure of desmocollin-2 (isoform 2a). SP
p signal peptide; Pp propeptide. The positions of the M477fsX480
and E896fsX900 mutations are marked.
the carboxyl-terminal domain of DSC2a are essential for
binding plakoglobin. Experiments in epithelial cells have
shown that desmocollin mutants lacking this short seg-
ment from the C terminus did not have the ability to bind
plakoglobin or to effect the formation of the desmosomal
plaque and the intermediate ﬁlaments’ anchorage.35 Mu-
tation E896fsX900 (in families B–D) is located in exon 17
and would affect the C terminus of DSC2 by altering 4 aa
residues before a termination codon is prematurely intro-
duced. In the absence of functional studies, it is difﬁcult
to predict exactly how these twomutations inDSC2would
affect desmosome formation. However, since desmocol-
lins are crucial in cell adhesion and tissue morphogenesis,
it can be speculated that absence of DSC2 or incorporation
of mutant DSC2 in desmosomes would result in structur-
ally and functionally impaired desmosomes. This would
be in agreement with the widely accepted “desmosomal
model” hypothesis. It is believed that, under conditions
of mechanical stress, impaired desmosome function due
to desmosomal gene mutations would lead to detachment
and death of cardiac myocytes followed by inﬂammation
and ﬁbrofatty replacement.5 However, recent data from
Garcia-Gras and colleagues on desmoplakin-deﬁcientmice
implicate a novel disease mechanism through inhibition
of the Wnt/b-catenin signaling network.36 Clearly, func-
tional studies of DSC2 mutants are required for the in-
vestigation of how mutations in desmocollin-2may result
in an ARVD/C phenotype.
The presence of the E896fsX900 mutation in four fam-
ilies indicates either that this insertion is recurrent in pa-
tients with ARVD/C who harbor DSC2 mutations or that
families B–D may have a common founder. However, hap-
lotype analysis with use of microsatellite DNA markers
(D18S847, D18S49, and D18S457) in close proximity to
the DSC2 locus in individuals carrying E896fsX900 iden-
tiﬁed no allele sharing (data not shown). This data would
suggest that E896fsX900 is a recurrent mutation.
Although desmocollin-2 expression in tissues is wide-
spread, individuals carrying a DSC2 mutation did not show
clinical evidence of hair or skin abnormalities. This is con-
sistent with previous studies in which only a cardiac phe-
notype was present in patients with plakophilin-2 and
DSG2 mutations.12–17 Therefore, it seems likely that DSC1
and DSC3 compensates for a dysfunctional DSC2 isoform
in epithelial cells but not in cardiac myocytes, where only
DSC2 is expressed.23
All mutation carriers in our families have clinical fea-
tures of ARVD/C (table 2). However, disease penetrance is
incomplete; consequently, not all our patients fulﬁll the
ARVD/C diagnostic criteria set out by the International
Task Force of the ESC/ISFC. Our ﬁnding is consistent with
previous ﬁndings in patients with ARVD/C caused by mu-
tations in desmoplakin, plakophilin-2, and DSG2.9,13,17 Fur-
thermore, since the publication of the current diagnostic
criteria, it has become clear that these criteria cannot be
effectively applied to relatives of deﬁnitely affected pro-
bands who have features of cardiomyopathy on clinical
evaluation. This issue was speciﬁcally addressed by Hamid
and colleagues, who found that the presence of certain ab-
normalities was, alone, sufﬁcient to make a diagnosis of
ARVD/C in a subject with a deﬁnitely affected relative.28
Application of these criteria to the relatives, as detailed in
table 2, enables amore realistic assessmentof cosegregation.
In ARVD/C, the classic presentation is with right ven-
tricular involvement, with an apparent progression to left
ventricular involvement. It is striking that ﬁve of seven
individuals in our group (II.2 and III.1 in family A, III.2
in family B, II.3 in family C, and II.2 in family D) had
evidence of signiﬁcant left ventricular involvement that
was more obvious than the right ventricular disease in two
individuals. Interestingly, in family A, the ECG of the pro-
band is suggestive of left ventricular predominance, but
the imaging studies demonstrate more-extensive right ven-
tricular involvement. The same phenomenon has been re-
ported elsewhere in a proband with a desmoplakin mu-
tation.9 The presence of left ventricular involvement in
patients with DSC2 mutations is consistent with previous
ﬁndings in ARVD/C associated with mutations in plako-
globin, desmoplakin, and DSG2 (27%, 27%, and 40% of
mutation carriers, respectively, had ECG and/or imaging
evidence of abnormalities in the left ventricle).9,16,37 The
ESC/ISFC criteria do not allow for left ventricular disease,
but our results would suggest that DSC2 mutations may
be more frequently associated with a predominately left
ventricular phenotype of ARVD/C or an arrhythmogenic
left ventricular cardiomyopathy without signiﬁcant right
ventricular involvement. However, since this study is lim-
ited by the small number of mutation carriers, this ﬁnding
will need to be conﬁrmed in larger kindreds in future
studies.
In conclusion, for the ﬁrst time, we have identiﬁed mu-
tations in desmocollin-2 in patients and family members
with ARVD/C. This ﬁnding is consistent with the hypoth-
esis that DSC2 is the ﬁfth desmosomal gene causing ARVD/
C and provides further evidence that ARVD/C is a disease
of cell adhesion.
www.ajhg.org The American Journal of Human Genetics Volume 79 November 2006 983
Acknowledgments
This work was supported by the British Heart Foundation and
the European Commission 5th Framework Program ARVC/D grant
QLG1-CT-2000-01091. We thank the patients and family mem-
bers for taking part in this study.
Web Resources
Accession numbers and URLs for data presented herein are as
follows:
GenBank, http://www.ncbi.nlm.nih.gov/Genbank/ (for DSC2a
[accession number NM_024422] and DSC2b [accession number
NM_004949])
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi
.nlm.nih.gov/Omim/ (for ARVD/C)
References
1. Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau
JL, Malergue C, Grosgogeat Y (1982) Right ventricular dys-
plasia: a report of 24 adult cases. Circulation 65:384–398
2. Corrado D, Basso C, Thiene G (2000) Arrhythmogenic right
ventricular cardiomyopathy: diagnosis, prognosis, and treat-
ment. Heart 83:588–595
3. Fontaine G, Fontaliran F, Hebert JL, Chemla D, Zenati O,
Lecarpentier Y, Frank R (1999) Arrhythmogenic right ven-
tricular dysplasia. Annu Rev Med 50:17–35
4. Corrado D, Fontaine G, Marcus FI, McKenna WJ, Nava A,
Thiene G, Wichter T, Study Group on Arrhythmogenic Right
Ventricular Dysplasia/Cardiomyopathy of theWorkingGroups
on Myocardial and Pericardial Disease and Arrhythmias of
the European Society of Cardiology and of the Scientiﬁc
Council on Cardiomyopathies of the World Heart Federation
(2000) Arrhythmogenic right ventricular cardiomyopathy:
need for an international registry. Circulation101:E101–E106
5. Sen-Chowdhry S, Syrris P, McKenna WJ (2005) Genetics of
right ventricular cardiomyopathy. J Cardiovasc Electrophy-
siol 16:927–935
6. McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anas-
tasakis A, Coonar A, Norman M, Baboonian C, Jeffery S, Mc-
Kenna WJ (2000) Identiﬁcation of a deletion in plakoglobin
in arrhythmogenic right ventricular cardiomyopathywithpal-
moplantar keratoderma and woolly hair (Naxos disease). Lan-
cet 355:2119–2124
7. Rampazzo A, Nava A, Malacrida S, Beffagna G, Bauce B, Rossi
V, Zimbello R, Simionati B, Basso C, Thiene G, Towbin JA,
Danieli GA (2002) Mutation in human desmoplakin domain
binding to plakoglobin causes a dominant form of arrhyth-
mogenic right ventricular cardiomyopathy. Am J HumGenet
71:1200–1206
8. NormanM, SimpsonM,Mogensen J, ShawA, Hughes S, Syrris
P, Sen-Chowdhry S, Rowland E, Crosby A, McKennaWJ (2005)
Novel mutation in desmoplakin causes arrhythmogenic left
ventricular cardiomyopathy. Circulation 112:636–642
9. Bauce B, Basso C, Rampazzo A, Beffagna G, Daliento L, Frigo
G, Malacrida S, Settimo L, Danieli G, Thiene G, Nava A (2005)
Clinical proﬁle of four families with arrhythmogenic right
ventricular cardiomyopathy caused by dominant desmoplakin
mutations. Eur Heart J 26:1666–1675
10. Norgett EE, Hatsell SJ, Carvajal-Huerta L, Cabezas JC, Com-
mon J, Purkis PE, Whittock N, Leigh IM, Stevens HP, Kelsell
DP (2000) Recessive mutation in desmoplakin disrupts desmo-
plakin-intermediate ﬁlament interactions and causes dilated
cardiomyopathy, woolly hair and keratoderma. HumMolGe-
net 9:2761–2766
11. Alcalai R, Metzger S, Rosenheck S, Meiner V, Chajek-Shaul T
(2003) A recessivemutation in desmoplakin causes arrythmo-
genic right ventricular dysplasia, skin disorder, and woolly
hair. J Am Coll Cardiol 42:319–327
12. Gerull B, Heuser A, Wichter T, Paul M, Basson CT,McDermott
DA, Lerman BB, Markowitz SM, Ellinor PT, MacRae CA, Peters
S, Grossmann KS, Michely B, Sasse-Klaassen S, Birchmeier W,
Dietz R, Breithardt G, Schulze-Bahr E, Thierfelder L (2004)
Mutations in the desmosomal protein plakophilin-2 are com-
mon in arrhythmogenic right ventricular cardiomyopathy.
Nat Genet 36:1162–1164
13. Syrris P, Ward D, Asimaki A, Sen-Chowdhry S, Ebrahim HY,
Evans A, Hitomi N, Norman M, Pantazis A, Shaw AL, Elliott
PM, McKenna WJ (2006) Clinical expression of plakophilin-
2 mutations in familial arrhythmogenic right ventricular car-
diomyopathy. Circulation 113:356–364
14. Dalal D, Molin LH, Piccini J, Tichnell C, James C, Bomma C,
Prakasa K, Towbin JA, Marcus FI, Spevak PJ, Bluemke DA,
Abraham T, Russell SD, Calkins H, Judge DP (2006) Clinical
features of arrhythmogenic right ventricular dysplasia/car-
diomyopathy associated with mutations in plakophilin-2.
Circulation 113:1641–1649
15. van Tintelen JP, Entius MM, Bhuiyan ZA, Jongbloed R, Wies-
feld AC,Wilde AA, van der Smagt J, Boven LG,MannensMM,
van Langen IM, Hofstra RM, Otterspoor LC, Doevendans PA,
Rodriguez LM, van Gelder IC, Hauer RN (2006) Plakophilin-
2 mutations are the major determinant of familial arrhyth-
mogenic right ventricular dysplasia/cardiomyopathy. Circu-
lation 113:1650–1658
16. Pilichou K, Nava A, Basso C, Beffagna G, Bauce B, Lorenzon
A, Frigo G, Vettori A, Valente M, Towbin J, Thiene G, Danieli
GA, Rampazzo A (2006) Mutations in desmoglein-2 gene are
associated with arrhythmogenic right ventricular cardiomy-
opathy. Circulation 113:1171–1179
17. AwadMM,Dalal D, Cho E, Amat-AlarconN, JamesC, Tichnell
C, Tucker A, Russell SD, Bluemke DA, Dietz HC, Calkins H,
Judge DP (2006) DSG2 mutations contribute to arrhythmo-
genic right ventricular dysplasia/cardiomyopathy. Am J Hum
Genet 79:136–142
18. Tiso N, Stephan DA, Nava A, Bagattin A, Devaney JM, Stanchi
F, Larderet G, Brahmbhatt B, Brown K, Bauce B, Muriago M,
Basso C, Thiene G, Danieli GA, Rampazzo A (2001) Identiﬁ-
cation of mutations in the cardiac ryanodine receptor gene
in families affected with arrhythmogenic right ventricular car-
diomyopathy type 2 (ARVD2). Hum Mol Genet 10:189–194
19. Bauce B, Rampazzo A, Basso C, Bagattin A, Daliento L, Tiso
N, Turrini P, Thiene G, Danieli GA, Nava A (2002) Screening
for ryanodine receptor type 2 mutations in families with ef-
fort-induced polymorphic ventricular arrhythmias and sud-
den death: early diagnosis of asymptomatic carriers. J AmColl
Cardiol 40:341–349
20. Beffagna G, Occhi G, Nava A, Vitiello L, Ditadi A, Basso C,
Bauce B, Carraro G, Thiene G, Towbin JA, Danieli GA, Ram-
pazzo A (2005) Regulatory mutations in transforming growth
factor-b3 gene cause arrhythmogenic right ventricular cardio-
myopathy type 1. Cardiovasc Res 65:366–373
21. Huber O (2003) Structure and function of desmosomal pro-
984 The American Journal of Human Genetics Volume 79 November 2006 www.ajhg.org
teins and their role in development and disease. Cell Mol Life
Sci 60:1872–1890
22. Garrod DR, Merritt AJ, Nie Z (2002) Desmosomal cadherins.
Curr Opin Cell Biol 14:537–545
23. Nuber UA, Scha¨fer S, Schmidt A, Koch PJ, Franke WW (1995)
The widespread human desmocollin Dsc2 and tissue-speciﬁc
patterns of synthesis of various desmocollin subtypes. Eur J
Cell Biol 66:69–74
24. Greenwood MD, Marsden MD, Cowley CM, Sahota VK, Bux-
ton RS (1997) Exon-intron organization of the human type
2 desmocollin gene (DSC2): desmocollin gene structure is
closer to “classical” cadherins than to desmogleins.Genomics
44:330–335
25. Syed SE, Trinnaman B, Martin S, Major S, Hutchinson J, Ma-
gee AI (2002) Molecular interactions between desmosomal
cadherins. Biochem J 362:317–327
26. Troyanovsky RB, Chitaev NA, Troyanovsky SM (1996) Cad-
herin binding sites of plakoglobin: localization, speciﬁcity and
role in targeting to adhering junctions. J Cell Sci 109:3069–
3078
27. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-
Lundqvist C, Fontaine G, Camerini F, Task Force of theWork-
ing Group Myocardial and Pericardial Disease of the Euro-
pean Society of Cardiology and of the Scientiﬁc Council on
Cardiomyopathies of the International Society and Federa-
tion of Cardiology (1994) Diagnosis of arrhythmogenic right
ventricular dysplasia/cardiomyopathy. Br Heart J 71:215–218
28. Hamid MS, Norman M, Quraishi A, Firoozi S, Thaman R,
Gimeno JR, Sachdev B, Rowland E, Elliott PM, McKenna WJ
(2002) Prospective evaluation of relatives for familial arrhyth-
mogenic right ventricular cardiomyopathy/dysplasia reveals
a need to broaden diagnostic criteria. J Am Coll Cardiol 40:
1445–1450
29. Hashimoto T, Kiyokawa C, Mori O, MiyasatoM, ChidgeyMA,
Garrod DR, Kobayashi Y, Komori K, Ishii K, Amagai M, Nishi-
kawa T (1997) Human desmocollin 1 (Dsc1) is an autoantigen
for the subcorneal pustular dermatosis type of IgA pemphi-
gus. J Invest Dermatol 109:127–131
30. Amagai M, Klaus-Kovtun V, Stanley JR (1991) Autoantibodies
against a novel epithelial cadherin in pemphigus vulgaris, a
disease of cell adhesion. Cell 67:869–877
31. Hunt DM, Rickman L,Whittock NV, Eady RA, Simrak D, Dop-
ping-Hepenstal PJ, Stevens HP, Armstrong DK, Hennies HC,
Kuster W, Hughes AE, Arnemann J, Leigh IM, McGrath JA,
Kelsell DP, Buxton RS (2001) Spectrum of dominant muta-
tions in the desmosomal cadherin desmoglein 1, causing the
skin disease striate palmoplantar keratoderma. Eur J Hum Ge-
net 9:197–203
32. Moss C, Martinez-Mir A, Lam H, Tadin-Strapps M, Kljuic A,
Christiano AM (2004) A recurrent intragenic deletion in the
desmoglein 4 gene underlies localized autosomal recessive
hypotrichosis. J Invest Dermatol 123:607–610
33. Chidgey M, Brakebusch C, Gustafsson E, Cruchley A, Hail C,
Kirk S, Merritt A, North A, Tselepis C, Hewitt J, Byrne C,
Fassler R, Garrod D (2001) Mice lacking desmocollin 1 show
epidermal fragility accompanied by barrier defects and ab-
normal differentiation. J Cell Biol 155:821–832
34. Garrod DR, Merritt AJ, Nie Z (2002) Desmosomal adhesion:
structural basis, molecular mechanism and regulation. Mol
Membr Biol 19:81–94
35. Troyanovsky SM, Troyanovsky RB, Eshkind LG, Leube RE,
FrankeWW (1994) Identiﬁcation of amino acid sequencemo-
tifs in desmocollin, a desmosomal glycoprotein, that are re-
quired for plakoglobin binding and plaque formation. Proc
Natl Acad Sci USA 91:10790–10794
36. Garcia-Gras E, Lombardi R, GiocondoMJ,Willerson JT, Schnei-
der MD, Khoury DS, Marian AJ (2006) Suppression of canon-
ical Wnt/b-catenin signaling by nuclear plakoglobin recapit-
ulates phenotype of arrhythmogenic right ventricular
cardiomyopathy. J Clin Invest 116:2012–2021
37. Protonotarios N, Tsatsopoulou A, Anastasakis A, Sevdalis E,
McKoy G, Stratos K, Gatzoulis K, Tentolouris K, Spiliopoulou
C, Panagiotakos D, McKenna W, Toutouzas P (2001) Geno-
type-phenotype assessment in autosomal recessive arrhyth-
mogenic right ventricular cardiomyopathy (Naxos disease)
caused by a deletion in plakoglobin. J Am Coll Cardiol 38:
1477–1484
